Complex cytokine profiles induced by BCG vaccination in UK infants
- PMID: 19941997
- PMCID: PMC2824844
- DOI: 10.1016/j.vaccine.2009.11.004
Complex cytokine profiles induced by BCG vaccination in UK infants
Abstract
IFNgamma plays an important part in immunity to tuberculosis (TB), but although it is necessary, it is not on its own sufficient for protection against TB. To identify other cytokines that play a role in the protection against TB induced by BCG vaccination, immune responses were compared between vaccinated and unvaccinated infants from the UK where BCG is known to provide protection. Twenty-one cytokines and chemokines were tested in supernatants from diluted whole blood cultures that had been stimulated for 6 days with Mycobacterium tuberculosis PPD. For 15 out of 21 of the cytokines tested responses were much higher in BCG vaccinated infants than in unvaccinated infants. These included: pro-inflammatory cytokines; IFNgamma (median 1705 pg/ml vs. 1.6 pg/ml in vaccinated and unvaccinated infants, respectively), TNFalpha (median 226 pg/ml vs. 18 pg/ml), as well as IL-2, IL-1alpha and IL-6; TH2 cytokines: IL-4, IL-5 and IL-13 (median 104 pg/ml vs. 1.6 pg/ml); the regulatory cytokine IL-10 (median response 96 pg/ml vs. 8 pg/ml); the TH17 cytokine IL-17, chemokines (IP-10, MIP-1alpha and IL-8) and growth factors (GM-CSF and G-CSF). The greatest increase in cytokine production in BCG vaccinees compared to unvaccinated infants was seen with IFNgamma. While responses for many cytokines were correlated with the IFNgamma response, others including IL-17 and IL-10 were not. The pattern of cytokine induction following BCG vaccination is complex and measurement of one of two cytokines does not reveal the whole picture of vaccine-induced protection.
Copyright (c) 2009 Elsevier Ltd. All rights reserved.
Figures



Similar articles
-
Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining.BMC Immunol. 2010 Jul 7;11:35. doi: 10.1186/1471-2172-11-35. BMC Immunol. 2010. PMID: 20609237 Free PMC article.
-
Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants.Vaccine. 2016 Oct 17;34(44):5298-5305. doi: 10.1016/j.vaccine.2016.09.002. Epub 2016 Sep 9. Vaccine. 2016. PMID: 27622301
-
BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi.J Infect Dis. 2011 Oct 1;204(7):1075-85. doi: 10.1093/infdis/jir515. J Infect Dis. 2011. PMID: 21881123 Free PMC article.
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
-
The immune response to BCG vaccination of newborns.Ann N Y Acad Sci. 2005 Dec;1062:69-78. doi: 10.1196/annals.1358.010. Ann N Y Acad Sci. 2005. PMID: 16461790 Review.
Cited by
-
Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.J Neurosci Res. 2013 Oct;91(10):1292-302. doi: 10.1002/jnr.23253. Epub 2013 Aug 1. J Neurosci Res. 2013. PMID: 23907992 Free PMC article.
-
A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis.PLoS One. 2013 Sep 16;8(9):e73230. doi: 10.1371/journal.pone.0073230. eCollection 2013. PLoS One. 2013. PMID: 24066041 Free PMC article.
-
Age-related waning of immune responses to BCG in healthy children supports the need for a booster dose of BCG in TB endemic countries.Sci Rep. 2018 Oct 17;8(1):15309. doi: 10.1038/s41598-018-33499-4. Sci Rep. 2018. PMID: 30333506 Free PMC article.
-
Immune Responses Following BCG Immunization of Infants in Uganda and United Kingdom Are Similar for Purified Protein Derivative but Differ for Secretory Proteins of Mycobacterium tuberculosis.Front Immunol. 2021 Mar 19;12:637114. doi: 10.3389/fimmu.2021.637114. eCollection 2021. Front Immunol. 2021. PMID: 33815390 Free PMC article.
-
Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity.Front Immunol. 2017 Dec 11;8:1755. doi: 10.3389/fimmu.2017.01755. eCollection 2017. Front Immunol. 2017. PMID: 29312298 Free PMC article. Review.
References
-
- World Health Organisation. Immunization, surveillance, assessment and monitoring. Reported estimates of BCG coverage; updated 16 December 2008, http://www.who.int/vaccines/globalsummary/immunization/timeseries/tscove... [accessed 08.05.09].
-
- Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet. 1995;346(8986):1339–1345. - PubMed
-
- Rodrigues L.C., Diwan V.K., Wheeler J.G. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 1993;22(6):1154–1158. - PubMed
-
- Gupta U.D., Katoch V.M., McMurray D.N. Current status of TB vaccines. Vaccine. 2007;25(19):3742–3751. - PubMed
-
- Kaufmann S.H., Parida S.K. Tuberculosis in Africa: learning from pathogenesis for biomarker identification. Cell Host Microbe. 2008;4(3):219–228. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources